ArticleJournal of oncology2012

Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Donavon HissPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.